Healthcare Sector

LLY

Market Tracker

$1,116.00
-1.26
(-0.11%)
1:40 am
Next Earnings: (est.) 08/08/23 12:00 am
  • LLY (Selected)

    Eli Lilly and Company
  • LLYVA

  • LLYVK

  • LLYX

LLY Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

LLY Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

LLY Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

LLY Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

LLY Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

LLY Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
07/17/2026 CALL $1,640.00 2,376 +704 +42.11%
07/02/2026 PUT $730.00 686 +685 +68,500.00%
07/17/2026 CALL $1,660.00 2,343 +631 +36.86%
07/02/2026 PUT $770.00 304 +302 +15,100.00%
09/18/2026 PUT $940.00 401 +266 +197.04%
08/21/2026 CALL $1,200.00 2,722 +230 +9.23%
06/26/2026 CALL $1,115.00 98 -40 -28.99%
07/24/2026 PUT $855.00 64 -47 -42.34%
06/26/2026 CALL $1,120.00 748 -54 -6.73%
06/26/2026 PUT $1,070.00 231 -59 -20.34%
07/17/2026 CALL $1,300.00 1,047 -61 -5.51%
07/24/2026 PUT $850.00 146 -88 -37.61%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

LLY Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.74% 26M 11.45B
Vanguard 500 Index Fund 1.92% 18.23M 8.03B
Vanguard/Primecap Fund 1.56% 14.85M 6.54B
Fidelity 500 Index Fund 0.91% 8.65M 3.81B
SPDR S&P 500 ETF Trust 0.90% 8.54M 3.76B
Vanguard Specialized-Health Care Fund 0.80% 7.64M 3.37B
iShares Core S&P 500 ETF 0.74% 7.04M 3.1B
Washington Mutual Investors Fund 0.73% 6.95M 3.06B
Growth Fund Of America Inc 0.71% 6.7M 2.95B
Select Sector SPDR Fund-Health Care 0.67% 6.41M 2.82B

LLY News

  • Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel

    06/25 07:30 am

    GlobeNewswire Inc.

    Read more
  • Zealthy Expands Insurance Coordination for GLP-1 Weight-Loss Medications

    06/23 04:52 pm

    GlobeNewswire Inc.

    Read more
  • Zealthy Launches Enhanced Weight-Loss Care Platform With Integrated Zepbound Access and Insurance Support

    06/23 01:56 pm

    GlobeNewswire Inc.

    Read more
  • Eli Lilly vs Viking Therapeutics: Which GLP-1 Stock Is the Better Buy?

    06/23 10:14 am

    The Motley Fool

    Read more
  • Positive FDA Feedback on Phase 3 Brings Entera Bio's Oral Osteoporosis Pill One Step Closer to Market

    06/23 08:50 am

    GlobeNewswire Inc.

    Read more
  • Oryn Therapeutics Advances Next Phase of Orynotide™ Macrocyclic Peptide Platform Development with Expanded Leadership Team and Board Anchored by Accomplished Life Sciences Industry Veterans, Company Builders and Drug Developers

    06/23 07:00 am

    GlobeNewswire Inc.

    Read more
  • 3 Monster Stocks to Hold for the Next 10 Years

    06/23 06:05 am

    The Motley Fool

    Read more
  • New Long-Term Data Shows Lebrikizumab Sustains Atopic Dermatitis Clearance With Less Frequent Dosing and Advances Findings from Dr. Philip Werschler of Spokane Dermatology Clinic

    06/22 02:55 pm

    GlobeNewswire Inc.

    Read more
  • Sitryx Completes Enrollment in Phase 1b Trial of First-in-Class Oral PKM2 Modulator SYX-5219 in Atopic Dermatitis

    06/22 07:00 am

    GlobeNewswire Inc.

    Read more
  • TheDoseReport Announces Which GLP-1 is Best? Semaglutide and Tirzepatide

    06/21 07:33 am

    GlobeNewswire Inc.

    Read more
  • Pfizer's Dividend Yield is 10X Bigger Than Eli Lilly's. Does That Make It the Better Stock for Income Investors?

    06/20 05:15 pm

    The Motley Fool

    Read more
  • The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own

    06/19 04:30 am

    The Motley Fool

    Read more
  • 3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound

    06/18 11:41 am

    Investing.com

    Read more
  • 3 Under-the-Radar Stocks to Buy and Hold for a Decade

    06/16 03:30 am

    The Motley Fool

    Read more
  • Confo Therapeutics Announces Encouraging Preclinical Data for Post-bariatric Hypoglycemia Candidate CFTX-2034 at ENDO 2026

    06/15 03:00 pm

    GlobeNewswire Inc.

    Read more
  • Novo Nordisk’s Wegovy Pill Turns Pricing Pain Into a Volume Bet

    06/15 02:07 pm

    Investing.com

    Read more
  • Eli Lilly Eyes Label Expansion For Leukemia Drug

    06/15 01:43 pm

    Benzinga

    Read more
  • Should You Buy Eli Lilly Stock Now or Wait for a Dip?

    06/15 12:30 pm

    The Motley Fool

    Read more
  • 3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow

    06/14 08:15 am

    The Motley Fool

    Read more
  • Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About

    06/12 12:32 pm

    The Motley Fool

    Read more
  • AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend.

    06/12 06:15 am

    The Motley Fool

    Read more
  • Is Viking Therapeutics Stock Going to $100?

    06/12 01:15 am

    The Motley Fool

    Read more
  • iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns

    06/10 02:17 pm

    The Motley Fool

    Read more
  • Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%

    06/10 01:27 pm

    The Motley Fool

    Read more
  • Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight

    06/10 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Why Eli Lilly Stock Climbed to a New All-Time High Today

    06/08 09:13 pm

    The Motley Fool

    Read more
  • Lilly Just Announced 3 Infectious Disease Acquisitions in 1 Day. Is This the Beginning of Its Post-Obesity Growth Strategy?

    06/08 05:23 pm

    The Motley Fool

    Read more
  • Stock Market Today, June 8: Marvell, Intel, and Micron Lead Tech Stock Rebound

    06/08 05:03 pm

    The Motley Fool

    Read more
  • Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as 5-HT3 Pathway, NOP Receptor, mGluR5 NAM, and Other | DelveInsight

    06/08 01:00 pm

    GlobeNewswire Inc.

    Read more
  • A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk.

    06/08 12:14 pm

    The Motley Fool

    Read more
  • Eli Lilly Highlights Weight Loss Benefits For Women Across Menopausal Stages

    06/08 10:03 am

    Benzinga

    Read more
  • Novo Nordisk Highlights Positive Weight-Loss Data Across Multiple Programs

    06/08 08:55 am

    Benzinga

    Read more
  • Pfizer's 6.7% Yield Looks Scary -- but the Dividend Story Is Stronger Than It Seems

    06/06 12:15 pm

    The Motley Fool

    Read more
  • Novo's Wegovy Pill Isn't Just Beating Expectations -- It's Obliterating Them. Is the Beaten-Down Stock a Buy Now?

    06/06 09:15 am

    The Motley Fool

    Read more
  • Stock Market Today, June 4: Broadcom Drags on Nasdaq at Midday

    06/04 12:39 pm

    The Motley Fool

    Read more
  • Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies

    06/04 12:17 pm

    Benzinga

    Read more
  • Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success

    06/04 09:27 am

    The Motley Fool

    Read more
  • Prediction: Eli Lilly Will Be Worth More Than SpaceX in 2 Years

    06/03 01:17 pm

    The Motley Fool

    Read more
  • 1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't

    06/03 12:05 pm

    The Motley Fool

    Read more
  • State Street's Health Care ETF Tops Invesco's on Yield and Returns

    06/02 07:10 am

    The Motley Fool

    Read more
  • Eli Lilly Deepens Innovation Push Through New Biopharma Collaborations

    06/01 01:19 pm

    Benzinga

    Read more
  • Lilly's New Drug Just Delivered the Largest Weight Loss Ever Seen in a Clinical Trial -- Here's What It Means for Investors

    05/30 08:15 am

    The Motley Fool

    Read more
  • The Smartest Growth Stocks to Buy With $2,000 Right Now

    05/30 06:15 am

    The Motley Fool

    Read more
  • Stock Market Today, May 28: Tech Stocks Rise as Snowflake Surges After $6 Billion Amazon Deal and Strong Earnings

    05/28 02:06 pm

    The Motley Fool

    Read more
  • Contrarian Opinion: Novo Nordisk Is A Better Buy Than Eli Lilly Right Now

    05/28 12:15 pm

    The Motley Fool

    Read more
  • VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost

    05/28 08:07 am

    The Motley Fool

    Read more
  • Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma

    05/28 07:00 am

    GlobeNewswire Inc.

    Read more
  • 5 Undervalued Stocks You Can Buy and Hold Forever

    05/28 04:15 am

    The Motley Fool

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: